Home › Glioma › Alabama › Birmingham
Glioma clinical trials in Birmingham, AL
6 studies for Glioma are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RecruitingPhase 1/2
- Children's Hospital of Alabama, Birmingham
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- University of Alabama at Birmingham Cancer Center, Birmingham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- University of Alabama, Birmingham
Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma
RecruitingEarly phase 1
- UAB, Birmingham
- UAB, Birmingham
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
RecruitingPhase 1
- University of Alabama at Birmingham, Children's of Alabama, Birmingham
Glioma trials in other cities
- New York City, NY25 studies
- Houston, TX23 studies
- Boston, MA20 studies
- Washington, DC19 studies
- Philadelphia, PA16 studies
- Columbus, OH15 studies
- Miami, FL15 studies
- San Francisco, CA14 studies
- Chicago, IL13 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- Los Angeles, CA10 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Overweight16 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.